Octavius Pharma has developed DC granules of Aripiprazole for making Aripiprazole plain & orally disintegrating tablets. Product has been developed to produce uniform particles that help give a better flow-ability and super compressibility and common granules compatible to compression for all three strengths. Finished tablet dissolution as per USP Test-3 timepoints. Finished tablet qualitative composition and dissolution profile is in line with the Innovator “Abilify”, Product complies as per USP monograph.
| Strength | 5 / 10 / 20 mg |
| Finished Dosage Form | Tablets |
| Finished Product Compliance | USP |
| API DMF | Available |
| CTD Dosssier | Available |
Aripiprazole: Aripiprazole is used to manage and treat schizophrenia, mania associated with bipolar I disorder, irritability associated with an autism spectrum disorder, disjunctive therapy in major depressive disorder, and Tourette syndrome.
GET IN TOUCH
For inquiries and collaboration opportunities, reach out to us today! Your gateway to innovative healthcare solutions awaits!
"*" indicates required fields